Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 711

1.

Sarcopenia: A Time for Action. An SCWD Position Paper.

Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD.

J Cachexia Sarcopenia Muscle. 2019 Sep 15. doi: 10.1002/jcsm.12483. [Epub ahead of print]

2.

Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.

Eriguchi R, Obi Y, Soohoo M, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Streja E.

Am J Nephrol. 2019 Sep 13:1-9. doi: 10.1159/000502998. [Epub ahead of print]

PMID:
31522173
3.

Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.

Ray KK, Nicholls SJ, Ginsberg HD, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Cummings JL, Sweeney M, Schwartz GG.

Am Heart J. 2019 Aug 9;217:72-83. doi: 10.1016/j.ahj.2019.08.001. [Epub ahead of print]

PMID:
31520897
4.

Machine Learning to Identify Dialysis Patients at High Death Risk.

Akbilgic O, Obi Y, Potukuchi PK, Karabayir I, Nguyen DV, Soohoo M, Streja E, Molnar MZ, Rhee CM, Kalantar-Zadeh K, Kovesdy CP.

Kidney Int Rep. 2019 Jun 22;4(9):1219-1229. doi: 10.1016/j.ekir.2019.06.009. eCollection 2019 Sep.

5.

Current Management of Patients With Acquired Solitary Kidney.

Tantisattamo E, Dafoe DC, Reddy UG, Ichii H, Rhee CM, Streja E, Landman J, Kalantar-Zadeh K.

Kidney Int Rep. 2019 Jul 11;4(9):1205-1218. doi: 10.1016/j.ekir.2019.07.001. eCollection 2019 Sep. Review.

6.

Implementing the "Advancing American Kidney Health Initiative" by Leveraging Nutritional and Dietary Management of Kidney Patients.

Moore LW, Kalantar-Zadeh K.

J Ren Nutr. 2019 Sep;29(5):357-360. doi: 10.1053/j.jrn.2019.07.004. No abstract available.

PMID:
31472903
7.

Predialysis coronary revascularization and postdialysis mortality.

Gaipov A, Molnar MZ, Potukuchi PK, Sumida K, Canada RB, Akbilgic O, Kabulbayev K, Szabo Z, Koshy SKG, Kalantar-Zadeh K, Kovesdy CP.

J Thorac Cardiovasc Surg. 2019 Mar;157(3):976-983.e7. doi: 10.1016/j.jtcvs.2018.08.107. Epub 2018 Sep 27.

PMID:
31431793
8.

Access to Care for VA Dialysis Patients During Superstorm Sandy.

Lukowsky LR, Dobalian A, Goldfarb DS, Kalantar-Zadeh K, Der-Martirosian C.

J Prim Care Community Health. 2019 Jan-Dec;10:2150132719863599. doi: 10.1177/2150132719863599.

9.

Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease.

Chua JT, Argueta DA, DiPatrizio NV, Kovesdy CP, Vaziri ND, Kalantar-Zadeh K, Moradi H.

Cannabis Cannabinoid Res. 2019 Mar 13;4(1):10-20. doi: 10.1089/can.2018.0060. eCollection 2019. Review.

10.

Association of US Dialysis Facility Staffing with Profiling of Hospital-Wide 30-Day Unplanned Readmission.

Chen Y, Rhee C, Senturk D, Kurum E, Campos L, Li Y, Kalantar-Zadeh K, Nguyen D.

Kidney Dis (Basel). 2019 Jun;5(3):153-162. doi: 10.1159/000496147. Epub 2019 Feb 5.

11.

Why the Nutritional Management of Acute Versus Chronic Kidney Disease Should Differ.

Kalantar-Zadeh K, Moore LW.

J Ren Nutr. 2019 Jul;29(4):265-268. doi: 10.1053/j.jrn.2019.05.002. No abstract available.

PMID:
31230723
12.

Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy.

Okuda Y, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K.

Pediatr Nephrol. 2019 Jun 19. doi: 10.1007/s00467-019-04270-2. [Epub ahead of print]

PMID:
31218394
13.

Hyponatremia in the Dialysis Population.

Rhee CM, Ayus JC, Kalantar-Zadeh K.

Kidney Int Rep. 2019 Mar 1;4(6):769-780. doi: 10.1016/j.ekir.2019.02.012. eCollection 2019 Jun. Review.

14.

Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.

Lertdumrongluk P, Streja E, Rhee CM, Moradi H, Chang Y, Reddy U, Tantisattamo E, Kalantar-Zadeh K, Kopp JB.

Cardiorenal Med. 2019;9(4):212-221. doi: 10.1159/000496472. Epub 2019 Apr 17.

PMID:
30995638
15.

Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers.

Koppe L, Fouque D, Kalantar-Zadeh K.

J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):479-484. doi: 10.1002/jcsm.12421. Epub 2019 Apr 12.

16.

Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients.

Suematsu Y, Goto M, Park C, Nunes ACF, Jing W, Streja E, Rhee CM, Cruz S, Kashyap ML, Vaziri ND, Narayanaswami V, Kalantar-Zadeh K, Moradi H.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4848-4856. doi: 10.1210/jc.2019-00334.

PMID:
30920627
17.

Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes.

Soohoo M, Moradi H, Obi Y, Rhee CM, Gosmanova EO, Molnar MZ, Kashyap ML, Gillen DL, Kovesdy CP, Kalantar-Zadeh K, Streja E.

J Am Heart Assoc. 2019 Mar 19;8(6):e011869. doi: 10.1161/JAHA.118.011869.

18.

Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients.

Kleine CE, Obi Y, Streja E, Hsiung JT, Park C, Holick MF, Kalantar-Zadeh K.

Bone. 2019 Jul;124:158-165. doi: 10.1016/j.bone.2019.03.003. Epub 2019 Mar 9.

PMID:
30858148
19.

Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents.

Okuda Y, Soohoo M, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K.

Am J Kidney Dis. 2019 Jun;73(6):797-805. doi: 10.1053/j.ajkd.2018.12.038. Epub 2019 Mar 2.

PMID:
30833086
20.

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V.

Am J Kidney Dis. 2019 Mar;73(3S1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21. No abstract available.

Supplemental Content

Loading ...
Support Center